C. B. Fleet Co
Form 483 issued April 18, 2025 · Lynchburg, Virginia
- Inspection
- Apr 14 – Apr 18, 2025
- Investigators
- David A. Oluwo· Homero W. Aguilar
- Observations
- 4
- Pages
- 8
- FEI number
- 1111503
In short: On April 18, 2025, FDA issued a Form 483 with 4 observations to C. B. Fleet Co in Lynchburg, Virginia (FEI 1111503) after an inspection that ran Apr 14 – Apr 18, 2025. The investigators were David A. Oluwo and Homero W. Aguilar. Most observations concern quality system and laboratory controls.
At a glance
Quality system and laboratory controls account for 4 of 4 observations.
What FDA observed
Preview: the opening words of each observation- 01
There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch…
- 02
Laboratory controls do not include the establishment of scientifically sound and appropriate sampling plans and test…
- 03
The specificity of test methods…
- 04
The responsibilities and procedures applicable to the quality control unit are not in…
This inspection in context
David A. Oluwo
27 documents · 2017–2026
Cites 211.192 (production record review) more than any other section. Most of their documents are for sites in Maryland.
The firmC. B. Fleet Co history
All 3 documents on file for this site, in date order, with what was cited at each inspection.
Similar 483sOther sites cited under 211.192
See how FDA wrote the same problem up elsewhere.
Questions about this 483
What did FDA find at C. B. Fleet Co?
FDA listed 4 observations on this Form 483, mostly about quality system and laboratory controls. The opening words of each observation are shown on this page.
Who inspected C. B. Fleet Co?
David A. Oluwo and Homero W. Aguilar are named on this Form 483, for the inspection of Apr 14 – Apr 18, 2025. Each investigator has a profile showing what they cite most.
When was C. B. Fleet Co inspected by FDA?
The inspection ran Apr 14 – Apr 18, 2025, and the Form 483 is dated April 18, 2025.
How do I get the full Form 483 for C. B. Fleet Co?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.